PubMatic Vs. CRISPR Therapeutics AG Industry Stock Comparison

Buy

53

PUBM
PubMatic

Last Price:

$11.82

Seasonality Move:

-17.38%

Sell

31

CRSP
CRISPR Therapeutics AG

Last Price:

$36.75

Seasonality Move:

5.8%

Buy

53

PubMatic (PUBM) is a Buy

Is PubMatic a Buy, Sell or Hold?

The current PubMatic [PUBM] share price is $12.13. The Score for PUBM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
PUBM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

31

CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

The current CRISPR Therapeutics AG [CRSP] share price is $37.23. The Score for CRSP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PUBM Stock Price Chart

What is PubMatic's stock price today?

The PubMatic share price today is $12.13

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PUBM is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

The CRISPR Therapeutics AG share price today is $37.23

The current trend is moderately bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

PUBM Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.51	Buy
Relative Strength Index (14 RSI):	71.95	Buy
Chaikin Money Flow:	484133	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(9.94 - 11.6)	Buy
Bollinger Bands (100):	(9.25 - 14.65)	Buy

CRSP Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.04	Buy
Relative Strength Index (14 RSI):	49.4	Sell
Chaikin Money Flow:	-1428832	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(35.85 - 38.73)	Sell
Bollinger Bands (100):	(36.02 - 43.96)	Sell

PUBM Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	11.54	Buy
20-day SMA:	10.99	Buy
50-day SMA:	9.92	Buy
200-day SMA:	13.64	Sell
8-day EMA:	11.58	Buy
20-day EMA:	11.07	Buy
50-day EMA:	10.84	Buy
200-day EMA:	13.49	Sell

CRSP Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	37.86	Sell
20-day SMA:	37.05	Buy
50-day SMA:	37.29	Sell
200-day SMA:	43.73	Sell
8-day EMA:	37.39	Sell
20-day EMA:	36.95	Buy
50-day EMA:	31.7	Buy
200-day EMA:	14.15	Buy

PubMatic Earnings Growth & PUBM Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.36 per share, and an increase next year of $0.27 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.14 per share, a decrease this year of $0.31 per share, and an increase next year of $1.03 per share.

PubMatic Technical Analysis

	May 14	May 15	May 16	May 19	May 20	May 21	May 22	May 23	May 27	May 28
	May
	14	15	16	19	20	21	22	23	27	28
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

	May 14	May 15	May 16	May 19	May 20	May 21	May 22	May 23	May 27	May 28
	May
	14	15	16	19	20	21	22	23	27	28
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):